---
title: "Aspen Neuroscience tumbles 8% in post-IPO pullback"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304516683.md"
description: "Aspen Neuroscience fell 8.15% to $11.72 after its amended charter took effect at the IPO close, raising about $140.6 million."
datetime: "2026-11-05T19:30:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304516683.md)
  - [en](https://longbridge.com/en/news/304516683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304516683.md)
generator: "portal-rs"
---

# Aspen Neuroscience tumbles 8% in post-IPO pullback

Aspen Neuroscience (ASPE.US) tumbled more than **8%** during regular trading to **$11.72**.

The company's amended charter took effect on Nov. 2, 2026, coinciding with the close of its initial public offering. Aspen Neuroscience issued **9,375,000** shares of common stock at **$15** per share, raising approximately **$140.6 million** before underwriting discounts and expenses.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ASPE.US](https://longbridge.com/en/quote/ASPE.US.md)

## Related News & Research

- [ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience](https://longbridge.com/en/news/304929595.md)
- [OrbiMed Advisors Discloses Investment at Aspen Neuroscience, Inc. with 12.3% Stake](https://longbridge.com/en/news/304700413.md)
- [Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing](https://longbridge.com/en/news/304014788.md)
- [OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares](https://longbridge.com/en/news/304354913.md)
- [Baidu (BIDU) Earnings Preview: Profits Seen Falling 46% Despite AI Cloud Boom](https://longbridge.com/en/news/305571383.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**